Molecular and Cellular Biochemistry

, Volume 315, Issue 1–2, pp 179–184 | Cite as

Leptin modulates the negative inotropic effect of interleukin-1β in cardiac myocytes

  • M. Judith Radin
  • Bethany J. Holycross
  • Cristian Dumitrescu
  • Robert Kelley
  • Ruth A. Altschuld


Interleukin-1β (IL-1β) is a potent negative inotrope implicated in the functional abnormalities of heart failure. Because the adipokine, leptin, protects against some of the cardiovascular effects of endotoxin, we hypothesized that leptin may modulate the cardiosuppressive effects of IL-1β in isolated cardiomyocytes. Ventricular cardiac myocytes isolated from adult male Sprague Dawley rats were analyzed simultaneously for electrically stimulated contractility and calcium transients following 30 min exposure to IL-1β (10 ng/ml) with or without 60 min pretreatment with leptin (25 ng/ml). IL-1β decreased cell shortening, depressed maximal velocities of shortening and relengthening, and prolonged the time to 90% relaxation. The change in fura2-AM fluorescence ratio amplitude (Δ[Ca2+]) was significantly depressed and the time to return to baseline [Ca2+] was prolonged. The negative inotropic effects of IL-1β were blocked by the neutral sphingomyelinase inhibitor Manumycin A (5 μM) or the ceramidase inhibitor N-oleoyl ethanolamine (1 μM). Prior exposure of myocytes to leptin blocked IL-1β-induced cardiosuppression in conjunction with a blunting of IL-1β stimulated ceramide accumulation. These data suggest that leptin may modulate IL-1β signaling through the sphingolipid signaling pathway in cardiomyocytes.


Leptin Interleukin-1β Cardiac myocytes Ceramide 


  1. 1.
    Blum A, Miller H (2001) Pathophysiological role of cytokines in congestive heart failure. Annu Rev Med 52:15–27. doi:10.1146/ PubMedCrossRefGoogle Scholar
  2. 2.
    Long CS (2001) The role of interleukin-1 in the failing heart. Heart Fail Rev 6:81–94. doi:10.1023/A:1011428824771 PubMedCrossRefGoogle Scholar
  3. 3.
    Favory R, Lancel S, Marchetti P, Mordon S, Chopin C, Formstecher P et al (2004) Endotoxin-induced myocardial dysfunction: Evidence for a role of sphingosine production. Crit Care Med 32:495–501. doi:10.1097/01.CCM.0000109452.36271.FA PubMedCrossRefGoogle Scholar
  4. 4.
    Schreur KD, Liu S (1997) Involvement of ceramide in inhibitory effect of IL-1 beta on L-type calcium current in adult rat ventricular myocytes. Am J Physiol Heart Circ Physiol 272:H2591–H2598Google Scholar
  5. 5.
    Sweeney G (2002) Leptin signaling. Cell Signal 12:655–663. doi:10.1016/S0898-6568(02)00006-2 CrossRefGoogle Scholar
  6. 6.
    Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R et al (1995) Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263–1271. doi:10.1016/0092-8674(95)90151-5 PubMedCrossRefGoogle Scholar
  7. 7.
    Hoggard N, Mercer JG, Rayner DV, Moar K, Trayhurn P, Williams LM (1997) Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RT-PCR and in situ hybridization. Biochem Biophys Res Commun 232:383–387. doi:10.1006/bbrc.1997.6245 PubMedCrossRefGoogle Scholar
  8. 8.
    Nickola MW, Wold LE, Colligan PB, Wang G-J, Samson WK, Ren J (2000) Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO. Hypertension 36:501–505PubMedGoogle Scholar
  9. 9.
    Faggioni R, Moser A, Feingold KR, Grunfeld C (2000) Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am J Pathol 156:1781–1787PubMedGoogle Scholar
  10. 10.
    Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR et al (1999) Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 276:R136–R142PubMedGoogle Scholar
  11. 11.
    Wimsatt DK, Hohl CM, Brierley GP, Altschuld RA (1990) Calcium accumulation and release by the sarcoplasmic reticulum of digitonin-lysed adult mammalian ventricular cardiomyocytes. J Biol Chem 265:14849–14857PubMedGoogle Scholar
  12. 12.
    Hohl CM, Altschuld RA (1991) Response of isolated adult canine cardiac myocytes to prolonged hypoxia and reoxygenation. Am J Physiol 260:C383–C391PubMedGoogle Scholar
  13. 13.
    Bergman MR, Holycross BJ (1996) Pharmacological modulation of myocardial tumor necrosis factor α production by phosphodiesterase inhibitors. J Pharmacol Exp Ther 279:247–254PubMedGoogle Scholar
  14. 14.
    Houle MS, Altschuld RA, Billman GE (2001) Enhanced in vivo and in vitro contractile responses to β2-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias. J Appl Physiol 91:1627–1637PubMedGoogle Scholar
  15. 15.
    Hensley J, Billman GE, Johnson JD, Hohl CM, Altschuld RA (1997) Effects of calcium channel antagonists on Ca2+ transients in rat and canine cardiomyocytes. J Mol Cell Cardiol 29:1037–1043. doi:10.1006/jmcc.1996.0348 PubMedCrossRefGoogle Scholar
  16. 16.
    Dasgupta S, Hogan EL (2001) Chromatographic resolution and quantitative assay of CNS tissue sphingoids and sphingolipids. J Lipid Res 42:301–307PubMedGoogle Scholar
  17. 17.
    Bishcel MD, Austin JH (1963) A modified benzidine method for the chromatographic detection of sphingolipids and acid polysaccharides. Biochim Biophys Acta 70:598–600. doi:10.1016/0006-3002(63)90800-X CrossRefGoogle Scholar
  18. 18.
    Huwiler A, Kolter T, Pfeilschifter J, Sandhoff K (2000) Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta 1485:63–99PubMedGoogle Scholar
  19. 19.
    Liu SJ, Kennedy RH (2003) Positive inotropic effect of ceramide in adult ventricular myocytes: mechanisms dissociated from its reduction in Ca++ influx. Am J Physiol Heart Circ Physiol 285:H735–H744PubMedGoogle Scholar
  20. 20.
    Relling DP, Hintz KK, Ren J (2003) Acute exposure of ceramide enhances cardiac contractile function in isolated ventricular myocytes. Br J Pharmacol 140:1163–1168. doi:10.1038/sj.bjp.0705510 PubMedCrossRefGoogle Scholar
  21. 21.
    Viani P, Giussani P, Brioschi L, Bassi R, Anelli V, Tettamanti G et al (2003) Ceramide in nitric oxide inhibition of glioma cell growth. Evidence for the involvement of ceramide traffic. J Biol Chem 278:9592–9601. doi:10.1074/jbc.M207729200 PubMedCrossRefGoogle Scholar
  22. 22.
    Franzen R, Fabbro D, Aschrafi A, Pfeilschifter J, Huwiler A (2002) Nitric oxide induces degradation of the neutral ceramidase in rat renal mesangial cells and is couterrregulated by protein kinase C. J Biol Chem 277:46184–46190. doi:10.1074/jbc.M204034200 PubMedCrossRefGoogle Scholar
  23. 23.
    Zhang Y, Scarpace PJ (2006) The role of leptin in leptin resistance and obesity. Physiol Behav 88:249–256. doi:10.1016/j.physbeh.2006.05.038 PubMedCrossRefGoogle Scholar
  24. 24.
    Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D et al (2000) Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 97:1784–1789. doi:10.1073/pnas.97.4.1784 PubMedCrossRefGoogle Scholar
  25. 25.
    Chabowski A, Zmijewska M, Gorski J, Bonen A, Kaminski K, Winnicka MM (2007) Effect of IL-6 deficiency on myocardial expression of fatty acid transporters and intracellular lipid deposits. J Physiol Pharmacol 58:73–82PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  • M. Judith Radin
    • 1
  • Bethany J. Holycross
    • 2
  • Cristian Dumitrescu
    • 2
  • Robert Kelley
    • 2
  • Ruth A. Altschuld
    • 3
  1. 1.Department of Veterinary BiosciencesThe Ohio State UniversityColumbusUSA
  2. 2.The Dorothy M. Davis Heart and Lung Research InstituteThe Ohio State UniversityColumbusUSA
  3. 3.Department of Molecular and Cellular BiochemistryThe Ohio State UniversityColumbusUSA

Personalised recommendations